Yes, your renal impairment is likely related to the PEP regimen, particularly if it contains tenofovir disoproxil fumarate (TDF).
The decline in your eGFR to 56 mL/min/1.73 m² with elevated creatinine (1.36 mg/dL) is consistent with tenofovir-associated nephrotoxicity, which typically manifests within the first 12 weeks of therapy and is usually reversible upon discontinuation.
Understanding Your Renal Function Changes
Your laboratory values show:
- eGFR of 56 = Stage 3A chronic kidney disease (mild-moderate reduction)
- BUN 25 mg/dL = mildly elevated
- Creatinine 1.36 mg/dL = elevated
This pattern is characteristic of TDF-related renal dysfunction, which occurs through progressive renal tubular injury 1, 2.
The Evidence on PEP-Related Kidney Injury
Expected Timeline and Magnitude
Research demonstrates that TDF/FTC causes:
- Initial drop in kidney function within the first 12 weeks: Mean creatinine increases by 0.03 mg/dL (4.6%), with CrCl decreasing by 4.8 mL/min (3.0%) 1
- 5.1% of patients develop new-onset eGFR <70 mL/min/1.73 m² during the first year 1
- Progressive decline continues at approximately -0.38 mL/min/1.73m² per month after the initial drop 2
Your eGFR of 56 represents a more significant decline than typical, placing you in the minority who experience clinically meaningful renal impairment.
Risk Factors That May Apply to You
Independent predictors of developing eGFR <70 include 1:
- Age ≥40 years (OR 3.79)
- Baseline eGFR <90 mL/min/1.73 m² (OR 9.59)
If you had any baseline renal compromise or are over 40, this substantially increases your risk.
Critical Next Steps
Immediate Actions Required
- Confirm the PEP regimen composition: If it contains TDF, this is almost certainly the culprit
- Check for proteinuria: 15.7% develop worsening proteinuria by week 12 1. Request a urine protein-to-creatinine ratio
- Consider cystatin C testing: This can differentiate true kidney injury from creatinine elevation due to other factors (muscle mass, supplements, medications that inhibit tubular creatinine secretion) 3
Management Algorithm
If you're still within the PEP course (typically 28 days):
- Contact your prescribing physician immediately
- Do NOT stop PEP without medical guidance (HIV exposure risk must be weighed)
- Your provider should consider switching to tenofovir alafenamide (TAF) instead of TDF, which has significantly less nephrotoxicity 4
- TAF is well-tolerated in mild-moderate renal impairment (CrCl >30 mL/min) 4
If PEP is completed:
- Renal function typically stabilizes and improves after discontinuation 1, 2
- Repeat creatinine and eGFR in 2-4 weeks to document recovery
- Most TDF-related nephrotoxicity is reversible 4
Important Caveats
Don't Assume It's Only PEP
While PEP is the likely cause, consider:
- Dehydration from the traumatic exposure incident
- Other nephrotoxic medications (NSAIDs, certain antibiotics)
- Pre-existing kidney disease that wasn't previously detected
- Acute tubular necrosis from other causes
The Creatinine Secretion Issue
Some antiretrovirals (integrase inhibitors like dolutegravir, certain protease inhibitors) inhibit tubular creatinine secretion, causing creatinine elevation without actual kidney injury 4. This results in stable 5-20 mL/min reductions in calculated clearance but doesn't represent true nephrotoxicity. However, your eGFR of 56 suggests more than just this benign effect.
Monitoring Going Forward
Guidelines recommend 5:
- Baseline serum creatinine before PrEP/PEP initiation
- Creatinine clearance at first quarterly visit for ongoing PrEP users
- For PEP, monitoring at completion and 2-4 weeks post-completion is prudent
Prognosis
The good news: Studies show that even when eGFR decline ≥25% occurs, it typically stabilizes after week 12 and improves upon discontinuation 1, 2. Only 0.4% of patients require permanent PEP/PrEP discontinuation due to renal concerns 2.
Your kidney function should recover once the medication is stopped, though close monitoring is essential to confirm this trajectory.